Literature DB >> 35936171

COVID-19 Presenting As Miller Fisher Syndrome in a Patient With a History of Guillain-Barré Syndrome: A Case Report.

Louay Aldabain1, Metri Haddaden2, Rehan Farooqi1, Malaz Alissa1.   

Abstract

Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2, primarily affects the respiratory system. While coronaviruses are not a common cause of neurological disease, they have been reported to cause direct central nervous system infection, as well as presumed para-infectious disorders. Here we report a very rare case of SARS-CoV-2 infection presenting as Miller Fisher syndrome with positive anti-GQ1b antibodies in a patient with a history of Guillain-Barré syndrome, which was treated with IV immunoglobulin resulting in marked improvement in her symptoms. Thus, a high index of suspicion and meticulous observation are the cornerstones to identifying possible uncommon presentations of COVID-19.
Copyright © 2022, Aldabain et al.

Entities:  

Keywords:  anti gq1b antibodies; ataxia; covid-19; diplopia; miller fisher syndrome; ophthalmoplegia

Year:  2022        PMID: 35936171      PMCID: PMC9351825          DOI: 10.7759/cureus.26588

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  20 in total

1.  COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.

Authors:  Marc Dinkin; Virginia Gao; Joshua Kahan; Sarah Bobker; Marialaura Simonetto; Paul Wechsler; Jasmin Harpe; Christine Greer; Gregory Mints; Gayle Salama; Apostolos John Tsiouris; Dana Leifer
Journal:  Neurology       Date:  2020-05-01       Impact factor: 9.910

2.  Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

Authors:  M Koga; M Gilbert; J Li; S Koike; M Takahashi; K Furukawa; K Hirata; N Yuki
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

3.  Atypical Variant of Guillain Barre Syndrome in a Patient with COVID-19.

Authors:  Megan M Lowery; Muhammad Taimur Malik; Joseph Seemiller; Cynthia S Tsai
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-11-07

Review 4.  COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.

Authors:  Anant Parasher
Journal:  Postgrad Med J       Date:  2020-09-25       Impact factor: 2.401

5.  COVID-19 Induced Miller Fisher Syndrome Presenting With Autonomic Dysfunction: A Unique Case Report and Review of Literature.

Authors:  Subhrajyoti Biswas; Ritwik Ghosh; Arpan Mandal; Alak Pandit; Dipayan Roy; Samya Sengupta; Kaustav De; Bikash Chandra Swaika; Julián Benito-León
Journal:  Neurohospitalist       Date:  2021-05-17

6.  Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19.

Authors:  G-U Kim; M-J Kim; S H Ra; J Lee; S Bae; J Jung; S-H Kim
Journal:  Clin Microbiol Infect       Date:  2020-05-01       Impact factor: 8.067

7.  Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).

Authors:  Jessica Fernández-Domínguez; Elena Ameijide-Sanluis; Carmen García-Cabo; Raquel García-Rodríguez; Valentín Mateos
Journal:  J Neurol       Date:  2020-05-26       Impact factor: 4.849

8.  Miller Fisher syndrome and COVID-19: is there a link?

Authors:  Amanda Ray
Journal:  BMJ Case Rep       Date:  2020-08-11

9.  A Case Report of Acute Motor and Sensory Polyneuropathy as the Presenting Symptom of SARS-CoV-2.

Authors:  Michael R Kopscik; Barbra K Giourgas; Bradley C Presley
Journal:  Clin Pract Cases Emerg Med       Date:  2020-08

10.  Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.

Authors:  M Senel; S Abu-Rumeileh; D Michel; T Garibashvili; K Althaus; J Kassubek; M Otto
Journal:  Eur J Neurol       Date:  2020-11       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.